Navigation

Leukaemia (lymphocytic) - bendamustine

Bendamustine for the treatment of chronic lymphocytic leukaemia

Status: History
Expected date of issue: April 2011
Process: STA
Topic area:
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Helen Starkie
Communications manager: Laura Gibson
Project manager: Lori Farrar
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 12 August 2010
1st appraisal committee meeting: 10 November 2010
Top


 

Consultees and commentators

Consultees

Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • Napp Pharmaceuticals (bendamustine)

Patient/carer groups

  • Chronic Lymphocytic Leukaemia Support Association (CLLSA)
  • Leukaemia CARE
  • Lymphoma Association

Professional groups

  • British Society for Haematology
  • Cancer Research UK
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians
  • United Kingdom Chronic Lymphocytic Leukaemia Forum

Others

  • Department of Health
  • Welsh Assembly Government

General

  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • NHS Quality Improvement Scotland

Comparator manufacturers

  • None

Relevant research groups

  • Leukaemia & Lymphoma Research

Evidence Review Group

  • National Institute for Health Research Health Technology Assessment Programme
  • Peninsula Technology Assessment Group, University of Exeter (PenTAG)

Associated Guideline Groups

  • None

Associated Public Health Groups

  • None

Top


 

Key documents

This page was last updated: 01 December 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.